🇺🇸 Calcium/Vitamin D in United States

9,421 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 9,421

Most-reported reactions

1. Off Label Use — 1,561 reports (16.57%)
2. Fatigue — 1,406 reports (14.92%)
3. Nausea — 1,033 reports (10.96%)
4. Diarrhoea — 1,006 reports (10.68%)
5. Headache — 872 reports (9.26%)
6. Arthralgia — 841 reports (8.93%)
7. Dizziness — 697 reports (7.4%)
8. Dyspnoea — 696 reports (7.39%)
9. Pain — 690 reports (7.32%)
10. Fall — 619 reports (6.57%)

Source database →

Frequently asked questions

Is Calcium/Vitamin D approved in United States?

Calcium/Vitamin D does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Calcium/Vitamin D in United States?

Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.